|Strong & consistent IP portfolio||Strategic partnerships|
|Commitment to protecting & defending SHL’s IP||Freedom to Operate (FTO)|
|In- and out-licensing opportunities||Solid track record in patent monitoring & patent mining|
SHL has developed a comprehensive Intellectual Property (IP) strategy that focuses on safeguarding and defending the IP of our products and offerings. To meet this goal, we have an in-house team of IP experts to support our own as well as our customers’ needs.
As a forward-looking company that has always invested in the R&D of new technologies, SHL has created one of the largest and strongest IP portfolios for a broad range of developed drug delivery devices and healthcare equipment. For SHL, a large and strong IP portfolio is instrumental for in- and out-licensing opportunities, and for business transactions such as strategic partnerships, mergers and acquisitions.
In order to actively maintain a global leadership in the R&D of medicament delivery devices and healthcare equipment, we are committed to the continuous enhancement of our IP protection and defending mechanism throughout the entire organization.
Through a consistent and focused administration that is dedicated to safeguarding SHL’s IP portfolio, and with the constant monitoring of the IP landscape, we ensure that none of our solutions infringe third-party IP rights. As a result, we are able to provide our customers with thoroughly protected and bespoke solutions for their market needs.